Items for Davis, Courtney

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 32.

Article

Davis, Courtney and Abraham, John (2011) Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulation. Sociology of Health and Illness, 33 (5). pp. 731-47. ISSN 0141-9889

Davis, Courtney and Abraham, John (2011) Rethinking Innovation Accounting in Pharmaceutical Regulation: A Case Study in the Deconstruction of Therapeutic Advance and Therapeutic Breakthrough. Science, Technology, and Human Values, 36 (4). pp. 791-815. ISSN 0162-2439

Davis, Courtney and Abraham, John (2011) A comparative analysis of risk management strategies in EU and US pharmaceutical regulation. Health, Risk and Society, 13. pp. 413-31. ISSN 1369-8575

Davis, C and Abraham, J (2011) The socio-political roots of pharmaceutical uncertainty in the evaluation of `innovative' diabetes drugs in the EU and the US. Social Science and Medicine, 72. pp. 1574-81. ISSN 0277-9536

Abraham, John and Davis, Courtney (2010) Discovery and Management of Adverse Drug Reactions: The Nomifensine Hypersensitivity Syndrome, 1977-1986. Social History of Medicine, 23 (1). pp. 153-173. ISSN 0951-631X

Abraham, John and Davis, Courtney (2009) Drug Evaluation and the Permissive Principle: Continuities and Contradictions between Standards and Practices in Antidepressant Regulation. Social Studies of Science, 39 (4). pp. 569-598. ISSN 0306-3127

Abraham, John and Davis, Courtney (2007) Deficits, expectations and paradigms in British and American drug safety assessment: prising open the black box of regulatory science. Science, Technology, and Human Values, 32 (4). pp. 399-431. ISSN 0162-2439

Abraham, John and Davis, Courtney (2007) Interpellative sociology of pharmaceuticals: problems and challenges for innovation and regulation in the 21st century. Technology Analysis and Strategic Management, 19 (3). pp. 387-402. ISSN 0953-7325

Abraham, John and Davis, Courtney (2006) Testing times: the emergence of the Practolol disaster and its challenge to British drug regulation in the modern period. Social History of Medicine, 19 (1). 21pp. ISSN 0951-631X

Abraham, John and Davis, Courtney (2005) Risking public safety: experts, the medical profession and 'acceptable' drug injury. Health, Risk and Society, 7 (4). pp. 379-95. ISSN 1369-8575

Abraham, John and Davis, Courtney (2005) A comparative analysis of drug safety withdrawals in the UK and US: implications for current regulatory thinking and policy? Social Science and Medicine, 61 (5). pp. 881-892. ISSN 0277-9536

Abraham, John and Davis, Courtney (2005) A comparative analysis of drug safety withdrawals in the UK and the US (1971-92): Implications for regulatory thinking and policy. Social Science and Medicine, 61 (5). pp. 881-892. ISSN 0898-9621

Book Section

Davis, Courtney and Abraham, John (2009) The role of standards in understanding the modern drug regulatory period. In: Bonah, C (ed.) Harmonizing drugs : standards in 20th-century pharmaceutical history. Glyphe. ISBN 9782358150163

Abraham, John, Davis, Courtney, Martin, P and Kraft, A (2006) Understanding the 'Productivity Crisis' in the Pharmaceutical Industry: Over-Regulation or Lack of Innovation? In: Webster, A (ed.) New Technologies in Health Care. Palgrave Macmillan, pp. 177-193. ISBN 9781403991300

Davis, Courtney and Bergman, D (2004) The Work of the Health and Safety Executive. Memorandum submitted by the Centre for Corporate Accountability. In: Commons Work and Pensions Select Committee, House of (ed.) The Work of the Health and Safety Executive and Commission Fourth Report of Session 2003-2004. The Stationary Office Limited. ISBN 9780215019202

Reports and working papers

Abraham, John and Davis, Courtney (2009) Drug Safety Regulation in the UK and the US in Changing Political Contexts. Project Report. Economic and Social Research Council.

Abraham, John and Davis, Courtney (2005) Regulation of Innovative Pharmaceuticals in the EU and the US. Project Report. Economic and Social Research Council.

Davis, Courtney (2004) Making companies safe: what works? Technical Report. Amicus the Union, London.

Davis, Courtney and Abraham, John (2002) Mapping the social and political dynamics of drug safety withdrawals in the UK and the US. Project Report. Economic and Social Research Council.

Conference or Workshop Item

Davis, Courtney and Abraham, John (2010) Public health and accelerated access to pharmaceuticals: disease politics or corporate bias? In: Health Action International, 1 June 2010., Amsterdam.

Abraham, John and Davis, Courtney (2010) Deconstructing pharmaceutical 'science', 'innovation', and 'therapeutic breakthrough': a case study in the ideologies and realities of drug regulation in the US and the supranational EU. In: Tracing Pharmacueticals' Conference, University of Edinburgh (17-20th June 2009).

Davis, Courtney and Abraham, John (2009) The permissive and precautionary principles in regulating clinical trials evidence for drug efficacy. In: Reassessing the governance of clinical trials, 9-11 March 2009, Dalhousie University, Halifax, Canada.

Davis, Courtney and Abraham, John (2008) The role of standards in understanding the modern drug regulatory period. In: European Science Foundation conference: standard drugs and drug standards, 4-5th December 2008, Univeristy of Strasbourg, France..

Davis, Courtney and Abraham, John (2008) Regulation of innovative pharmaceuticals in the EU and US: a comparative analysis. In: Society for the Social Studies of Science (4S) and European Association for the Study of Science and Technology (EASST), 19-22 August 2008., Erasmus University, Rotterdam..

Davis, Courtney (2006) The HSE, Hampton and Evidence-Based Policy. In: Centre for Corporate Accountability: The Future of Safety Regulation and Enforcement, London 3rd March 2006.

Bergman, David, Davis, Courtney and Rigby, Bethan (2005) Comparative study of the law on director responsibilities for health and safety in other countries. In: Health and Safety Executive Conference: "Director responsibility for health and safety. What the evidence shows", London 6th October 2005.

Abraham, John and Davis, Courtney (2005) Risk Management, New Drug Assessment and the Health Adequacy of Health Protection. In: Second Annual Meeting of Health Technology Assessment International, Rome, Italy 20-22nd June 2005.

Davis, Courtney (2004) Effective strategies for regulating occupational health and safety: an overview of the international research. In: IOSH Public Services Group's National Safety Symposium, 6th September 2004, Portsmouth.

Davis, Courtney and Abraham, John (2004) Innovation, Expectation and Regulation: industry, public and regulatory understanding of innovation in contemporary pharmaceutical markets. In: Innovation Health Technologies Programme Conference 2004, Manchester.

Davis, Courtney and Abraham, John (2004) An International Comparative Analysis of Pharmaceutical Regulation in the EU and the US. In: Public Proofs: Science, Technology and Democracy, Paris, France 25-28th August 2004.

Davis, Courtney (2004) Regulation of occupational health and safety in the UK: shifts in policy and practice. In: Regulating Corporate Crime: Developments Across Europe, 2-4 September 2004, Finnish Police College, Helsinki.

Book

Davis, Courtney and Abraham, John (2013) Unhealthy pharmaceutical regulation: innovation, politics and promissory science. Health, technology and society . Palgrave Macmillan, Basingstoke. ISBN 9780230008663

This list was generated on Mon Apr 24 19:48:49 2017 BST.